uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$15.9000
-0.0200 ( -1.06% ) 4.7K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$15.9000

Previous close


$15.9200

Volume


4.7K

Market cap


$780.49M

Day range


$15.6200 - $16.4490

52 week range


$3.7300 - $19.1800

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 12, 2024
4 Insider transactions 1 Dec 10, 2024
8-k 8K-related 15 Dec 10, 2024
4 Insider transactions 1 Dec 10, 2024
8-k 8K-related 15 Nov 21, 2024
10-q Quarterly Reports 70 Nov 05, 2024
8-k 8K-related 15 Nov 05, 2024
8-k 8K-related 15 Oct 15, 2024
8-k 8K-related 15 Sep 23, 2024
8-k 8K-related 15 Aug 15, 2024

Latest News